Marie Scully Selected Research

Marie Scully Research Topics

Disease

51	Thrombotic Thrombocytopenic Purpura 05/2024 - 10/2006
16	Thrombocytopenia (Thrombopenia) 05/2024 - 03/2014
15	Thrombotic Microangiopathies 02/2023 - 01/2014
13	Thrombosis (Thrombus) 12/2022 - 01/2016
12	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 03/2024 - 11/2015
8	acquired Thrombotic thrombocytopenic purpura 01/2022 - 08/2011
7	COVID-19 12/2022 - 01/2020
7	Hemorrhage 12/2022 - 02/2016
6	Atypical Hemolytic Uremic Syndrome 06/2021 - 10/2016
5	Pre-Eclampsia (Preeclampsia) 11/2023 - 10/2018
5	Hemolytic-Uremic Syndrome 02/2023 - 01/2017
5	Hemolysis 02/2023 - 10/2018
4	Infections 12/2022 - 08/2011
4	Purpura 01/2022 - 09/2006
3	Chronic Kidney Failure (Chronic Renal Failure) 10/2021 - 01/2018
3	Headache (Headaches) 12/2020 - 11/2019
3	Stroke (Strokes) 11/2019 - 09/2006
3	Disseminated Intravascular Coagulation 01/2019 - 01/2017
2	Anaphylaxis (Anaphylactic Shock) 01/2022 - 01/2018
2	Serum Sickness 01/2022 - 01/2019
2	Venous Thrombosis (Deep-Vein Thrombosis) 01/2022 - 01/2021
2	Intracranial Sinus Thrombosis (Sinus Thrombosis) 10/2021 - 09/2021
2	Neoplasms (Cancer) 10/2020 - 01/2019
2	Disease Progression 10/2020 - 01/2020
2	Ischemic Stroke 01/2020 - 01/2015
2	Hemolytic Anemia 01/2019 - 03/2014
2	Sepsis (Septicemia) 01/2019 - 01/2017
1	Body Weight (Weight, Body) 05/2024
1	Thrombasthenia (Glanzmann Thrombasthenia) 01/2023
1	Migraine Disorders (Migraine) 01/2023
1	Respiratory Insufficiency (Respiratory Failure) 11/2022
1	Fat Embolism 11/2022
1	Severe Acute Respiratory Syndrome 01/2022
1	Hypersensitivity (Allergy) 01/2022
1	Mood Disorders (Mood Disorder) 01/2022
1	Rare Diseases (Rare Disease) 01/2022
1	Pregnancy-Induced Hypertension (Hypertension, Pregnancy Induced) 12/2021
1	Acute Kidney Injury (Acute Renal Failure) 06/2021
1	Chronic Renal Insufficiency 06/2021
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2021
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 11/2020
1	Eclampsia 11/2020
1	Bone Marrow Failure Disorders 10/2020
1	Brain Injuries (Brain Injury) 01/2020
1	Transient Ischemic Attack 01/2020
1	Epistaxis (Nosebleed) 01/2020

Drug/Important Bio-Agent (IBA)

39	thiamine triphosphorate (TTP)IBA 05/2024 - 09/2006
11	VaccinesIBA 12/2022 - 01/2021
10	caplacizumabIBA 01/2023 - 02/2016
9	Complement System Proteins (Complement)IBA 02/2023 - 03/2014
9	Metalloproteases (Metalloproteinases)IBA 01/2023 - 02/2007
9	AntibodiesIBA 01/2022 - 02/2007
9	Rituximab (Mabthera)FDA Link 01/2022 - 02/2007
8	von Willebrand FactorIBA 11/2023 - 01/2015
8	DisintegrinsIBA 01/2023 - 02/2007
8	ThrombospondinsIBA 01/2023 - 02/2007
7	Inosine Triphosphate (ITP)IBA 03/2024 - 11/2015
6	EnzymesIBA 02/2023 - 10/2018
6	ChAdOx1 nCoV-19IBA 12/2022 - 01/2021
5	Immunoglobulin G (IgG)IBA 01/2023 - 02/2007
5	AntigensIBA 12/2022 - 02/2007
5	fibrin fragment D (D-dimer)IBA 01/2022 - 01/2021
5	Heparin (Liquaemin)FDA LinkGeneric 01/2022 - 01/2016
5	AutoantibodiesIBA 01/2021 - 02/2007
4	ravulizumabIBA 06/2021 - 01/2020
4	Complement Inactivating AgentsIBA 05/2021 - 10/2018
3	Platelet Factor 4IBA 01/2022 - 01/2021
3	eculizumab FDA Link 10/2021 - 01/2018
2	Thrombopoietin ReceptorsIBA 03/2024 - 01/2018
2	eltrombopag FDA Link 03/2024 - 01/2017
2	Monoclonal AntibodiesIBA 01/2022 - 11/2019
2	Fibrinogen (Factor I)FDA Link 01/2022 - 10/2021
2	Factor VIII (Coagulation Factor VIII)IBA 01/2022 - 10/2006
2	ofatumumab FDA Link 01/2022 - 01/2018
2	Complement C5 (Complement 5)IBA 10/2021 - 06/2021
2	AnticoagulantsIBA 01/2021 - 01/2016
2	Intravenous Immunoglobulins (IVIG)FDA Link 11/2019 - 12/2018
2	Blood Coagulation Factors (Coagulation Factor)IBA 01/2019 - 01/2018
2	Dacarbazine (DIC)FDA LinkGeneric 01/2019 - 01/2018
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 12/2018 - 11/2015
2	Complement C3a (Complement 3a)IBA 10/2016 - 03/2014
1	romiplostim FDA Link 03/2024
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2023
1	Tyrosine (L-Tyrosine)FDA Link 11/2023
1	sutimlimabIBA 01/2023
1	Immunoglobulin A (IgA)IBA 01/2023
1	ImmunosorbentsIBA 01/2022
1	BNT162 VaccineIBA 01/2022
1	obinutuzumabIBA 01/2022
1	A-factor (Streptomyces)IBA 10/2021
1	COVID-19 VaccinesIBA 09/2021
1	Immunoglobulins (Immunoglobulin)IBA 01/2021
1	C-Reactive ProteinIBA 10/2020

Therapy/Procedure

12	Therapeutics 05/2024 - 04/2012
8	Plasma Exchange 11/2022 - 02/2007
2	Aftercare (After-Treatment) 01/2023 - 01/2017
2	Catheters 01/2022 - 01/2020
1	Hemofiltration 01/2022
1	Extracorporeal Membrane Oxygenation 01/2022
1	Immunotherapy 10/2020